We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Approach Cooks Cancer Cells

By Biotechdaily staff writers
Posted on 17 Aug 2005
A new approach to killing tumors uses the beam from a near-infrared laser to heat carbon nanotubes that have been selectively directed to the cancer cells.

While biologic systems are highly transparent to 700-1,100 nm near-infrared (NIR) light, a solution of carbon nanotubes exposed to NIR light warms to about 70oC within two minutes. More...
Investigators at Stanford University (Palo Alto, CA, USA) have exploited this property of carbon nanotubes to selectively destroy cancer cells.

They coated nanotubes with folate molecules that directed the nanotubes to folate receptors on the cancer cell membranes. After the cells took up the nanotubes, the tumors were exposed to NIR laser light. The light caused the nanotubes to heat up, and the heat killed the cells. Nearby normal cells with no nanotubes were not damaged by the laser treatment. These findings were published in the August 8, 2005, online edition of the Proceedings of the [U.S.] Academy of Sciences.

"One of the longstanding problems in medicine is how to cure cancer without harming normal body tissue,” explained senior author Dr. Hongjie Dai, associate professor of chemistry at Stanford University. "We are using an intrinsic property of nanotubes to develop a weapon that kills cancer.”




Related Links:
Stanford University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

Accurately predicting cardiovascular disease (CVD) risk in older adults is challenging when assessments rely on single, point-in-time biomarker measurements. Dynamic indicators that reflect evolving cardiac... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.